Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio As CMO
(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a company focused on oncology and obesity, said on Monday that it has appointed Leonardo Viana Nicacio as Chief Medical Officer.
Prior to joining Corbus, Nicacio was the CMO of Protara Therapeutics Inc.(TARA), a clinical-stage developer of therapies for the treatment of cancer and rare diseases.
Prior to Protara, Nicacio served as Senior Vice President, Head of Clinical Development and Global Medical Affairs at Stemline Therapeutics, a subsidiary of the Menarini Group.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.